Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Catalytic dysregulation of SHP2 leading to Noonan syndromes impacts on platelet signaling and functions.

Bellio M, Garcia C, Edouard T, Voisin S, Neel BG, Cabou C, Valet P, Mori J, Mazharian A, Senis YA, Yart A, Payrastre B, Severin S.

Blood. 2019 Sep 27. pii: blood.2019001543. doi: 10.1182/blood.2019001543. [Epub ahead of print]

PMID:
31562133
2.

Database shares that transform research subjects into partners.

Kain R, Kahn S, Thompson D, Lewis D, Barker D, Bustamante C, Cabou C, Casdin A, Garcia F, Paragas J, Patrinos A, Rajagopal A, Terry SF, Van Zeeland A, Yu E, Erlich Y, Barry D.

Nat Biotechnol. 2019 Oct;37(10):1112-1115. doi: 10.1038/s41587-019-0278-9. No abstract available.

PMID:
31537916
3.

Pharmacological inhibition of the F1 -ATPase/P2Y1 pathway suppresses the effect of apolipoprotein A1 on endothelial nitric oxide synthesis and vasorelaxation.

Cabou C, Honorato P, Briceño L, Ghezali L, Duparc T, León M, Combes G, Frayssinhes L, Fournel A, Abot A, Masri B, Parada N, Aguilera V, Aguayo C, Knauf C, González M, Radojkovic C, Martinez LO.

Acta Physiol (Oxf). 2019 Jul;226(3):e13268. doi: 10.1111/apha.13268. Epub 2019 Apr 4.

4.

Impact of PI3Kα (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis.

Laurent PA, Hechler B, Solinhac R, Ragab A, Cabou C, Anquetil T, Severin S, Denis CV, Mangin PH, Vanhaesebroeck B, Payrastre B, Gratacap MP.

Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2041-2053. doi: 10.1161/ATVBAHA.118.311410.

PMID:
30354258
5.

Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis.

Valéra MC, Noirrit-Esclassan E, Dupuis M, Fontaine C, Lenfant F, Briaux A, Cabou C, Garcia C, Lairez O, Foidart JM, Payrastre B, Arnal JF.

Mol Cell Endocrinol. 2018 Dec 5;477:132-139. doi: 10.1016/j.mce.2018.06.010. Epub 2018 Jun 19.

PMID:
29928930
6.

A dual role for the class III PI3K, Vps34, in platelet production and thrombus growth.

Valet C, Levade M, Chicanne G, Bilanges B, Cabou C, Viaud J, Gratacap MP, Gaits-Iacovoni F, Vanhaesebroeck B, Payrastre B, Severin S.

Blood. 2017 Nov 2;130(18):2032-2042. doi: 10.1182/blood-2017-04-781641. Epub 2017 Sep 13.

7.

PI3Kβ Plays a Key Role in Apolipoprotein A-I-Induced Endothelial Cell Proliferation Through Activation of the Ecto-F1-ATPase/P2Y1 Receptors.

Castaing-Berthou A, Malet N, Radojkovic C, Cabou C, Gayral S, Martinez LO, Laffargue M.

Cell Physiol Biochem. 2017;42(2):579-593. doi: 10.1159/000477607. Epub 2017 Jun 5.

8.

Protective Hematopoietic Effect of Estrogens in a Mouse Model of Thrombosis: Respective Roles of Nuclear Versus Membrane Estrogen Receptor α.

Valéra MC, Fontaine C, Lenfant F, Cabou C, Guillaume M, Smirnova N, Kim SH, Chambon P, Katzenellenbogen JA, Katzenellenbogen BS, Payrastre B, Arnal JF.

Endocrinology. 2015 Nov;156(11):4293-301. doi: 10.1210/en.2015-1522. Epub 2015 Aug 17.

9.

Essential role of class II PI3K-C2α in platelet membrane morphology.

Valet C, Chicanne G, Severac C, Chaussade C, Whitehead MA, Cabou C, Gratacap MP, Gaits-Iacovoni F, Vanhaesebroeck B, Payrastre B, Severin S.

Blood. 2015 Aug 27;126(9):1128-37. doi: 10.1182/blood-2015-03-636670. Epub 2015 Jun 24.

PMID:
26109204
10.

Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins.

Martinez LO, Najib S, Perret B, Cabou C, Lichtenstein L.

Atherosclerosis. 2015 Jan;238(1):89-100. doi: 10.1016/j.atherosclerosis.2014.11.017. Epub 2014 Nov 20. Review.

PMID:
25437896
11.

Development and validation of liquid chromatography combined with tandem mass spectrometry methods for the quantitation of simalikalactone E in extracts of Quassia amara L. and in mouse blood.

Le HL, Jullian V, Claparols C, Vansteelandt M, Haddad M, Cabou C, Deharo E, Fabre N.

Phytochem Anal. 2015 Mar-Apr;26(2):111-8. doi: 10.1002/pca.2542. Epub 2014 Nov 27.

PMID:
25431121
12.

Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion.

Serhan N, Cabou C, Verdier C, Lichtenstein L, Malet N, Perret B, Laffargue M, Martinez LO.

Biochim Biophys Acta. 2013 Apr;1831(4):719-25. doi: 10.1016/j.bbalip.2012.12.006. Epub 2012 Dec 20.

PMID:
23266391
13.

Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α.

Valéra MC, Gratacap MP, Gourdy P, Lenfant F, Cabou C, Toutain CE, Marcellin M, Saint Laurent N, Sié P, Sixou M, Arnal JF, Payrastre B.

Blood. 2012 Aug 23;120(8):1703-12. doi: 10.1182/blood-2012-01-405498. Epub 2012 Jul 9.

PMID:
22776819
14.

GLP-1, the gut-brain, and brain-periphery axes.

Cabou C, Burcelin R.

Rev Diabet Stud. 2011 Fall;8(3):418-31. doi: 10.1900/RDS.2011.8.418. Epub 2011 Nov 10. Review.

15.

Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ.

Cabou C, Vachoux C, Campistron G, Drucker DJ, Burcelin R.

Diabetes. 2011 Sep;60(9):2245-56. doi: 10.2337/db11-0464. Epub 2011 Aug 1.

16.

Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.

Waget A, Cabou C, Masseboeuf M, Cattan P, Armanet M, Karaca M, Castel J, Garret C, Payros G, Maida A, Sulpice T, Holst JJ, Drucker DJ, Magnan C, Burcelin R.

Endocrinology. 2011 Aug;152(8):3018-29. doi: 10.1210/en.2011-0286. Epub 2011 Jun 14.

PMID:
21673098
17.

Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo.

Martin V, Guillermet-Guibert J, Chicanne G, Cabou C, Jandrot-Perrus M, Plantavid M, Vanhaesebroeck B, Payrastre B, Gratacap MP.

Blood. 2010 Mar 11;115(10):2008-13. doi: 10.1182/blood-2009-04-217224. Epub 2010 Jan 11.

PMID:
20065293
18.

A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism.

Burcelin R, Serino M, Cabou C.

Curr Opin Pharmacol. 2009 Dec;9(6):744-52. doi: 10.1016/j.coph.2009.09.003. Epub 2009 Sep 30. Review.

PMID:
19800290
19.

Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.

Cabou C, Campistron G, Marsollier N, Leloup C, Cruciani-Guglielmacci C, Pénicaud L, Drucker DJ, Magnan C, Burcelin R.

Diabetes. 2008 Oct;57(10):2577-87. doi: 10.2337/db08-0121. Epub 2008 Jul 15.

20.

Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.

Knauf C, Cani PD, Ait-Belgnaoui A, Benani A, Dray C, Cabou C, Colom A, Uldry M, Rastrelli S, Sabatier E, Godet N, Waget A, Pénicaud L, Valet P, Burcelin R.

Endocrinology. 2008 Oct;149(10):4768-77. doi: 10.1210/en.2008-0180. Epub 2008 Jun 12.

PMID:
18556349
21.

[Adverse drug reactions in pregnant women].

Lacroix I, Cabou C, Montastruc JL, Damase-Michel C.

Therapie. 2007 Sep-Oct;62(5):455-60. doi: 10.2515/therapie:2007067. Epub 2008 Jan 19. French.

PMID:
18206108
22.

Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes.

Cabou C, Cani PD, Campistron G, Knauf C, Mathieu C, Sartori C, Amar J, Scherrer U, Burcelin R.

Diabetes. 2007 Dec;56(12):2872-7. Epub 2007 Sep 5.

23.

[Myocardial infarction in a young female smoker taking oral contraception].

Cabou C, Lacroix I, Roncalli J, Elbaz M, Caillaux D, Damase-Michel C, Fauvel JM, Montastruc JL.

Arch Mal Coeur Vaiss. 2006 Jan;99(1):80-5. French.

PMID:
16479896
24.

[Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service].

Cabou C, Bagheri H, Cantagrel A, Mazières B, Montastruc JL.

Therapie. 2003 Sep-Oct;58(5):457-62. Review. French.

PMID:
14682196
25.

[Finger agenesis after in utero exposure to ketoconazole: a case report].

Cabou C, Lacroix I, Rista C, Rolland M, Chassaing N, Calvas P, Montastruc JL, Damase-Michel C.

Therapie. 2003 Mar-Apr;58(2):172-4. French. No abstract available.

PMID:
12942862

Supplemental Content

Support Center